Edgestream Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Buy
13,469
+10,574
+365% +$970K 0.04% 597
2025
Q4
$260K Buy
+2,895
New +$275K 0.01% 902
2025
Q1
Sell
-5,987
Closed -$632K 1120
2024
Q4
$632K Sell
5,987
-8,900
-60% -$955K 0.03% 647
2024
Q3
$1.61M Sell
14,887
-533
-3% -$58.2K 0.07% 460
2024
Q2
$1.67M Buy
+15,420
New +$1.82M 0.08% 388
2024
Q1
Sell
-10,514
Closed -$1.28M 1052
2023
Q4
$1.28M Buy
+10,514
New +$1.17M 0.09% 370
2022
Q1
Sell
-86,286
Closed -$10.6M 658
2021
Q4
$10.6M Buy
86,286
+84,830
+5,826% +$11.1M 0.66% 25
2021
Q3
$207K Buy
+1,456
New +$214K 0.01% 470
2021
Q1
Sell
-7,577
Closed -$1.13M 458
2020
Q4
$1.13M Buy
+7,577
New +$1.07M 0.06% 281
2020
Q3
Sell
-18,365
Closed -$2.13M 374
2020
Q2
$2.13M Buy
18,365
+2,481
+16% +$286K 0.11% 195
2020
Q1
$1.56M Buy
+15,884
New +$2.08M 0.14% 162
2019
Q4
Sell
-1,542
Closed -$205K 360
2019
Q3
$205K Sell
1,542
-28,001
-95% -$3.62M 0.02% 252
2019
Q2
$3.38M Buy
+29,543
New +$3.46M 0.38% 86
2019
Q1
Sell
-3,826
Closed -$385K 305
2018
Q4
$385K Buy
+3,826
New +$430K 0.07% 190

Other funds holding ZBH

Edgestream Partners's ZBH Position: Q1 2026 in Review

Edgestream Partners increased its Zimmer Biomet (ZBH) stake by 365% in Q1 2026, buying an estimated $970K and bringing the position to 13,469 shares worth $1.22M. The position accounts for 0.04% of the portfolio, ranked #597.

Edgestream Partners first reported a position in ZBH in Q4 2018 and has held it in 14 quarters since. The position peaked at $10.6M in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Edgestream Partners held 13,469 shares of Zimmer Biomet worth $1.22M as of Q1 2026.
  • Edgestream Partners bought 10,574 Zimmer Biomet shares in Q1 2026, an estimated $970K.
  • Zimmer Biomet made up 0.04% of Edgestream Partners's portfolio in Q1 2026, its #597 holding.
  • Edgestream Partners first reported a position in Zimmer Biomet in Q4 2018 and has held it in 14 quarters since.
  • Edgestream Partners's Zimmer Biomet position peaked at $10.6M in Q4 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.